QA: Akebia Therapeutics Inc in us_pharma/2025

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001517022_2026_Akebia_Therapeutics_Inc.pdf

Logs

Graph

Absolute values for 0001517022, Akebia Therapeutics Inc

  xvar xval
0 AssetsCurrent 252,955,000
1 IntangibleAssetsNetIncludingGoodwill 59,044,000
2 PropertyPlantAndEquipmentNet 1,222,000
3 remainder_Assets 63,344,000
4 LiabilitiesCurrent 162,938,000
5 LiabilitiesNoncurrent 50,073,000
6 remainder_Liabilities 130,944,000
7 CostOfGoodsAndServicesSold 34,690,860
8 SellingGeneralAndAdministrativeExpense 108,234,304
9 ResearchAndDevelopmentExpense 94,901,608
10 remainder_Expenses 6,808,112
11 remainder_Revenues 247,770,712
12 remainder_NetIncome -22,309,212
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 376,565,000
1 Liabilities 343,955,000
2 Expenses 244,634,884
3 Revenues 247,770,712
4 StockholdersEquity 32,610,000
5 NetIncome -19,173,384
6 ComprehensiveNetIncome -19,173,384
7 BaseVar 617,617,404
8 EconomicCapitalRatiobeforeLimitedLiability 0.144
9 EconomicCapitalRatio 1.55

Edgar->Model Mapping

Feature Distribution

Change over Time